Core Viewpoint - The relocation of Jinhyun Group's Shenzhen operation center marks a significant step in leveraging the advantages of Hainan's free trade policies and integrating into the Greater Bay Area's innovation and international resource networks [3][5][7] Group 1: Company Overview - Jinhyun Group, established in 2016 and headquartered in Hainan Free Trade Port, is the first company from Hainan to be listed in the U.S. [3] - The company operates under the mission of making global trade simpler and more reliable, providing a comprehensive service system that includes transaction matching, supply chain management, compliance support, and business landing [3] Group 2: Strategic Development - The new Shenzhen operation center will serve as a business coordination hub for the Greater Bay Area, an international resource docking window, and an innovation project incubation platform [5] - The center aims to enhance the group's responsiveness in global supply chains and cross-border services by strengthening connections with Hong Kong, Macau, and international markets [5] Group 3: Industry Focus - Jinhyun Group is actively responding to the national strategy of "Healthcare + Artificial Intelligence," expanding its layout in the pharmaceutical health and wellness industry while maintaining its core cross-border e-commerce business [5] - The company has established a stable cooperation network in regions such as Hong Kong and Japan for cross-border pharmaceutical collaboration, ensuring reliable, compliant, and traceable supply chain support for health products [5][6] Group 4: Compliance and Market Insight - The company adheres strictly to legal and regulatory requirements in the pharmaceutical and cross-border trade sectors, aiming to provide safe, effective, and trustworthy health products [6] - Through deep collaboration with health product channels in Hong Kong, the company gains insights into market demands, continuously optimizing its product structure and service system [6]